This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Low-Dose Lithium Augmentation of Divalproex in Geriatric Mania

Joseph F. Goldberg, Michael H. Sacks, and James H. Kocsis

Published: September 30, 2000

Article Abstract

Letter to the Editor

Sir: It is widely believed that antimanic efficacy with lithiumrequires doses at a level sufficient to achieve blood levels > 0.7mEq/L, although few data exist about bipolar patients who mayrespond to doses producing lower serum levels. In addition, asanticonvulsant mood stabilizers enter wider use, little is knownabout whether some bipolar patients respond preferentially tolithium or to combinations of lithium and anticonvulsants. Wereport 2 cases of geriatric mania that occurred after lithium discontinuationdue to neurotoxicity.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Populations

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...